Glycosylated serum protein may improve our ability to predict endothelial and erectile dysfunction in nonorganic patients

Journal of Sexual Medicine

Volumn 8, Issue 3, 2011, Pages 840-850

  Huang, Yanping ^a   Sun, Xiangzhou ^a   Liu, Guihua ^a   Yao, Fengjuan ^a   Zheng, Fufu ^a   Dai, Yuping ^a   Tu, Xiangan ^a   Xie, Xiaoyan ^a   Deng, Liwen ^a   Zhang, Dingmei ^a   Zhang, Yadong ^a   Bian, Jun ^a   Gao, Yong ^a   Ye, Yunlin ^a   Deng, Chunhua ^a   Zhang, Yuanyuan ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular Risk and Erectile Dysfunction; Endothelial Dysfunction; Flow mediated Dilation; Glycosylated Serum Protein; Non organic

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; CREATININE; GLUCOSE; GLYCOSYLATED PLASMA PROTEIN; GLYCOSYLATED PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROLACTIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URIC ACID;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL PARAMETERS; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CHINESE; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; ERECTILE DYSFUNCTION; FLOW MEDIATED DILATION; GLUCOSE BLOOD LEVEL; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM;

EID: 79952000717     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.02141.x     Document Type: Article

References (47)

1. Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999;84:50-6.
2. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.
3. McKinlay JB. The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res 2000;12(4 suppl):S6-S11.
4. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. Sexual function in men older than 50 years of age: Results from the health professionals follow-up study. Ann Intern Med 2003;139:161-8.
5. Bal K, Oder M, Sahin AS, Karataş CT, Demir O, Can E, Gümüş BH, Ozer K, Sahin O, Esen AA. Prevalence of metabolic syndrome and its association with erectile dysfunction among urologic patients: Metabolic backgrounds of erectile dysfunction. Urology 2007;69:356-60.
6. Musicki B, Liu T, Lagoda GA, Strong TD, Sezen SF, Johnson JM, Burnett AL. Hypercholesterolemia-induced erectile dysfunction: Endothelial nitric oxide synthase (eNOS) uncoupling in the mouse penis by NAD(P)H oxidase. J Sex Med 2010;7:3023-32.
7. Jackson G, Montorsi P, Adams MA, Anis T, El-Sakka A, Miner M, Vlachopoulos C, Kim E. Cardiovascular aspects of sexual medicine. J Sex Med 2010;7:1608-26.
8. Wang JL, Wang HG, Gao HQ, Zhai GX, Chang P, Chen YG. Endothelial nitric oxide synthase polymorphisms and erectile dysfunction: A meta-analysis. J Sex Med 2010 Aug 16 [Epub ahead of print] doi: 10.1111/j.1743-6109.2010.01968.x.
9. Burke JP, Jacobson DJ, McGree ME, Nehra A, Roberts RO, Girman CJ, Lieber MM, Jacobsen SJ. Diabetes and sexual dysfunction: Results from the Olmsted County study of urinary symptoms and health status among men. J Urol 2007;177:1438-42.
10. Giuliano FA, Leriche A, Jaudinot EO, de Gendre AS. Prevalence of erectile dysfunction among 7, 689 patients with diabetes or hypertension, or both. Urology 2004;64:1196-201.
11. Saigal CS, Wessells H, Pace J, Schonlau M, Wilt TJ. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med 2006;166:207-12.
12. Nikoobakht M, Nasseh H, Pourkasmaee M. The relationship between lipid profile and erectile dysfunction. Int J Impot Res 2005;17:523-6.
13. Toque HA, Romero MJ, Tostes RC, Shatanawi A, Chandra S, Carneiro ZN, Inscho EW, Webb RC, Caldwell RB, Caldwell RW. p38 Mitogen-activated protein kinase (MAPK) increases arginase activity and contributes to endothelial dysfunction in corpora cavernosa from angiotensin-II-treated mice. J Sex Med 2010 Aug 30 [Epub ahead of print] doi: 10.1111/j.1743-6109.2010.01996.x.
14. Gades NM, Nehra A, Jacobson DJ, McGree ME, Girman CJ, Rhodes T, Roberts RO, Lieber MM, Jacobsen SJ. Association between smoking and erectile dysfunction: A population-based study. Am J Epidemiol 2005;161:346-51.
15. Corona G, Mannucci E, Petrone L, Ricca V, Mansani R, Cilotti A, Balercia G, Chiarini V, Giommi R, Forti G, Maggi M. Psychobiological correlates of smoking in patients with erectile dysfunction. Int J Impot Res 2005;17:527-34.
16. Montorsi F. Assessment, diagnosis, and investigation of erectile dysfunction. Clin Cornerstone 2005;7:29-35.
17. Guest JF, Das Gupta R. Health-related quality of life in a UK-based population of men with erectile dysfunction. Pharmacoeconomics 2002;20:109-17.
18. Bokhour BG, Clark JA, Inui TS, Silliman RA, Talcott JA. Sexuality after treatment for early prostate cancer: Exploring the meanings of "erectile dysfunction". J Gen Intern Med 2001;16:649-55.
19. Muller A, Mulhall JP. Cardiovascular disease, metabolic syndrome and erectile dysfunction. Curr Opin Urol 2006;16:435-43.
20. Grover SA, Lowensteyn I, Kaouache M, Marchand S, Coupal L, DeCarolis E, Zoccoli J, Defoy I. The prevalence of erectile dysfunction in the primary care setting: Importance of risk factors for diabetes and vascular disease. Arch Intern Med 2006;166:213-9.
21. Clements RS Jr, Robison WG Jr, Cohen MP. Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice. J Diabetes Complications 1998;12:28-33.
22. Schalkwijk CG, Ligtvoet N, Twaalfhoven H, Jager A, Blaauwgeers HG, Schlingemann RO, Tarnow L, Parving HH, Stehouwer CD, van Hinsbergh VW. Amadori albumin in type 1 diabetic patients: Correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes 1999;48:2446-53.
23. Hattori Y, Kakishita H, Akimoto K, Matsumura M, Kasai K. Glycated serum albumin-induced vascular smooth muscle cell proliferation through activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by protein kinase C. Biochem Biophys Res Commun 2001;281:891-6.
24. Ghanem H, Shamloul R. An evidence-based perspective to commonly performed erectile dysfunction investigations. J Sex Med 2008;5:1582-9.
25. Rosen RC. Evaluation of the patient with erectile dysfunction: History, questionnaires, and physical examination. Endocrine 2004;23:107-11.
26. McLaughlin SP, Carson CC. Laboratory evaluation of the patient with erectile dysfunction. Endocrine 2004;23:113-7.
27. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822-30.
28. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11:319-26.
29. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-5.
30. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R; International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-65.
31. Alkhayal S, Lehmann V, Thomas P. A simple noninvasive test to detect vascular disease in patients with erectile dysfunction: A novel method. J Sex Med 2006;3:331-6.
32. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: Testing and clinical relevance. Circulation 2007;115:1285-95.
33. Lojanapiwat B, Weerusawin T, Kuanprasert S. Erectile dysfunction as a sentinel marker of endothelial dysfunction disease. Singapore Med J 2009;50:698-701.
34. Montorsi F, Briganti A, Salonia A, Rigatti P, Margonato A, Macchi A, Galli S, Ravagnani PM, Montorsi P. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol 2003;44:360-4; discussion 64-5.
35. Brevetti G, Silvestro A, Schiano V, Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: Additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 2003;108:2093-8.
36. Celermajer DS. Brachial artery FMD with 5-minute distal cuff occlusion-A useful pathophysiological test after all! J Appl Physiol 2005;99:1619.
37. Kovacs I, Csaszar A, Toth J, Siller G, Farkas A, Tarján J, Horváth J, Koller A. Correlation between flow-mediated dilation and erectile dysfunction. J Cardiovasc Pharmacol 2008;51:148-53.
38. Faulx MD, Wright AT, Hoit BD. Detection of endothelial dysfunction with brachial artery ultrasound scanning. Am Heart J 2003;145:943-51.
39. Kaiser DR, Billups K, Mason C, Wetterling R, Lundberg JL, Bank AJ. Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 2004;43:179-84.
40. Vlachopoulos C, Ioakeimidis N, Terentes-Printzios D, Stefanadis C. The triad: Erectile dysfunction-Endothelial dysfunction-Cardiovascular disease. Curr Pharm Des 2008;14:3700-14.
41. Furumoto T, Fujii S, Saito N, Mikami T, Kitabatake A. Relationships between brachial artery flow mediated dilation and carotid artery intima-media thickness in patients with suspected coronary artery disease. Jpn Heart J 2002;43:117-25.
42. Thakore AH, Guo CY, Larson MG, Corey D, Wang TJ, Vasan RS, D'Agostino RB Sr, Lipinska I, Keaney JF Jr, Benjamin EJ, O'Donnell CJ. Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol 2007;99:1598-602.
43. Bocchio M, Scarpelli P, Necozione S, Pelliccione F, Mhialca R, Spartera C, Francavilla F, Francavilla S. Intima-media thickening of common carotid arteries is a risk factor for severe erectile dysfunction in men with vascular risk factors but no clinical evidence of atherosclerosis. J Urol 2005;173:526-9.
44. Johansen JS, Harris AK, Rychly DJ, Ergul A. Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice. Cardiovasc Diabetol 2005;4:5.
45. Avogaro A, de Kreutzenberg SV, Fadini G. Endothelial dysfunction: Causes and consequences in patients with diabetes mellitus. Diabetes Res Clin Pract 2008;82(2 suppl):S94-101.
46. Zhang M, Kho AL, Anilkumar N, Chibber R, Pagano PJ, Shah AM, Cave AC. Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: Involvement of Nox2 (gp91phox)-containing NADPH oxidase. Circulation 2006;113:1235-43.
47. Basta G, Lazzerini G, Del Turco S, Ratto GM, Schmidt AM, De Caterina R. At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products. Arterioscler Thromb Vasc Biol 2005;25:1401-7.